Kidney Disease



The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Tangshen Prescription;   Drug: Placebos
Sponsors:   Guang'anmen Hospital of China Academy of Chinese Medical Sciences;   Anhui Provincial Hospital of Traditional Chinese Medicine;   Zhengzhou City Hospital of Traditional Chinese Medicine;   Shijiazhuang City Hospital of Traditional Chinese Medicine;   Baoding City Hospital of Traditional Chinese Medicine;   Hubei Hospital of Traditional Chinese Medicine;   Changchun Hospital of Traditional Chinese Medicine;   Xingtai City Hospital of Traditional Chinese Medicine;   Medicine Zibo Wanjie Tumor Hospital;   Zouping Country Hospital of Traditional Chinese Medicine;   She Country Hospital of Traditional Chinese Medicine;   Beijing Hospital of TCM;   Baishi Hospital
Not yet recruiting - verified January 2017


Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease


Condition:   Chronic Kidney Disease
Intervention:   Drug: D6-25-hydroxyvitamin D3
Sponsors:   University of Washington;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified May 2017


Early-Stage Polycystic Kidney Disease Biomarkers Repository Study


Condition:   Polycystic Kidney Disease
Intervention:  
Sponsors:   University of Kansas Medical Center;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified October 2016


A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease


Condition:   Autosomal Dominant Polycystic Kidney Disease
Interventions:   Dietary Supplement: High water intake;   Other: Ad libitum water intake
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   PKD Charity;   Addenbrookes Charitable Trust;   British Renal Society & British Kidney Patient Association
Not yet recruiting - verified October 2016


Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)


Condition:   Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions:   Drug: Tolvaptan;   Drug: Matching Placebo
Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting - verified April 2017


Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease


Condition:   Chronic Kidney Disease
Intervention:   Drug: Bixalomer
Sponsor:   Astellas Pharma Inc
Recruiting - verified February 2017


NEPHSTROM for Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Placebo
Sponsors:   Mario Negri Institute for Pharmacological Research;   Leiden University Medical Center;   ASST Papa Giovanni XXIII, Bergamo, Italy;   IRCCS - Istituto di Ricerche Farmacologiche Mario Negri - Bergamo, Italy;   Belfast Health and Social Care Trust;   National University of Ireland, Galway, Ireland;   University Hospital Birmingham, NHS Foundation Trust, Hospital, Birmingham, UK;   NHS Blood and Transplant
Not yet recruiting - verified May 2017


Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)


Condition:   Polycystic Kidney Disease
Interventions:   Dietary Supplement: Niacinamide;   Other: Placebo
Sponsors:   University of Kansas Medical Center;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified November 2016


Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease


Condition:   Chronic Kidney Disease
Interventions:   Drug: Micro-particle Curcumin;   Drug: Placebo
Sponsors:   Lawson Health Research Institute;   The Kidney Foundation of Canada;   Canadian Institutes of Health Research (CIHR)
Recruiting - verified March 2017


Whole Body Vibration in Kidney Disease


Condition:   Kidney Disease
Intervention:   Procedure: Whole Body Vibration
Sponsor:   Universidade Federal de Pernambuco
Completed - verified November 2016


Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease


Condition:   Autosomal Dominant Polycystic Kidney Disease
Intervention:   Drug: Tolvaptan (OPC-41061)
Sponsor:   Otsuka Pharmaceutical Development & Commercialization, Inc.
Enrolling by invitation - verified April 2017


New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease


Conditions:   Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:  
Sponsor:   Mayo Clinic
Completed - verified May 2016


Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease


Condition:   Diabetic Kidney Disease
Interventions:   Drug: Selonsertib;   Drug: Placebo to match selonsertib
Sponsor:   Gilead Sciences
Completed - verified January 2017


KoreaN Cohort Study for Outcome in Pediatric Patients With Chronic Kidney Disease


Condition:   Chronic Kidney Disease(CKD)
Intervention:  
Sponsors:   Seoul National University Hospital;   Jeju National University Hospital;   Pusan National University Hospital;   Samsung Medical Center;   Kyungpook National University;   Yonsei University;   Asan Medical Center
Active, not recruiting - verified October 2016


Effects of a Walking Intervention in Older Patients With Chronic Kidney Disease: Feasibility Study


Condition:   Chronic Kidney Disease
Intervention:   Behavioral: walking
Sponsors:   University of Utah;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified November 2016


Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease


Condition:   Polycystic Kidney Disease
Intervention:   Dietary Supplement: Niacinamide
Sponsor:   Alan Yu, MB, BChir
Completed - verified November 2016


Using a Diabetic Kidney Disease (DKD) Registry to Treat to Multiple Targets (TMT)


Condition:   Diabetic Kidney Disease
Interventions:   Other: Telephone Reminder;   Other: Doctor-Nurse Follow Up;   Other: Personalized Risk Report for Patient Empowerment
Sponsor:   Asia Diabetes Foundation
Recruiting - verified August 2016


Lanreotide In Polycystic Kidney Disease Study


Condition:   Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions:   Drug: Lanreotide;   Drug: saline
Sponsors:   Assistance Publique - Hôpitaux de Paris;   IPSEN pharmaceutical company, Boulogne-Billancourt, France
Recruiting - verified August 2016


Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease


Condition:   Chronic Kidney Disease
Interventions:   Behavioral: Conventional low protein diet;   Dietary Supplement: Very low protein diet supplemented with Ketosteril
Sponsors:   Anemia Working Group Romania;   Dr Carol Davila Teaching Hospital of Nephrology Bucharest
Completed - verified January 2017


Repository Study of Autosomal Dominant Polycystic Kidney Disease


Condition:   Autosomal Dominant Polycystic Kidney Disease
Intervention:  
Sponsors:   The Rogosin Institute;   Weill Medical College of Cornell University;   New York Presbyterian Hospital
Withdrawn - verified March 2017


Effects of High Dietary Fiber Supplementation in Diabetic Chronic Kidney Disease


Condition:   Kidney Disease
Intervention:   Dietary Supplement: psyllium
Sponsor:   University of Utah
Completed - verified August 2016


Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency


Condition:   Autosomal Dominant Polycystic Kidney Disease
Interventions:   Drug: Octreotide-LAR;   Other: Saline solution.
Sponsor:   Mario Negri Institute for Pharmacological Research
Active, not recruiting - verified May 2017


Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease


Condition:   Autosomal Dominant Polycystic Kidney Disease
Intervention:  
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation - verified January 2016


Polycystic Kidney Disease Data Repository


Condition:   Polycystic Kidney Disease
Intervention:  
Sponsors:   The Rogosin Institute;   Weill Medical College of Cornell University;   New York Presbyterian Hospital
Recruiting - verified August 2016


Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease


Condition:   Chronic Kidney Disease
Intervention:   Device: Diffuse Optical Spectroscopy
Sponsors:   University of California, Irvine;   Beckman Laser Institute University of California Irvine
Completed - verified February 2017

Refine Your Search Advanced Search